{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:44:58Z","timestamp":1790505898169,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"27","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.vaccine.2018.05.093","type":"journal-article","created":{"date-parts":[[2018,5,28]],"date-time":"2018-05-28T12:56:10Z","timestamp":1527512170000},"page":"3908-3916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Examination of the effects of virus inactivation methods on the induction of antibody- and cell-mediated immune responses against whole inactivated H9N2 avian influenza virus vaccines in chickens"],"prefix":"10.1016","volume":"36","author":[{"given":"Jake","family":"Astill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamiru","family":"Alkie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Yitbarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Taha-Abdelaziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jegarubee","family":"Bavananthasivam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9va","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James John","family":"Petrik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayan","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.05.093_b0005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.coviro.2017.10.006","article-title":"Host and virus ecology as determinants of influenza A virus transmission in wild birds","volume":"28","author":"van Dijk","year":"2018","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2018.05.093_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13567-017-0453-2","article-title":"Current situation of H9N2 subtype avian influenza in China","volume":"48","author":"Gu","year":"2017","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2018.05.093_b0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4142\/jvs.2016.17.1.27","article-title":"Assessment of the safety and efficacy of low pathogenic avian influenza (H9N2) virus in inactivated oil emulsion vaccine in laying hens","volume":"17","author":"Shin","year":"2016","journal-title":"J Vet Sci"},{"key":"10.1016\/j.vaccine.2018.05.093_b0020","doi-asserted-by":"crossref","unstructured":"Pawar SD, Tandale B V, Raut CG, Parkhi SS, Barde TD, Gurav YK, et al. Avian influenza H9N2 seroprevalence among poultry workers in Pune, India, 2010. PLoS One 2012;7. 10.1371\/journal.pone.0036374.","DOI":"10.1371\/journal.pone.0036374"},{"key":"10.1016\/j.vaccine.2018.05.093_b0025","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1056\/NEJMc0900358","article-title":"Antibodies against H5 and H9 Avian Influenza among Poultry Workers in China","volume":"360","author":"Wang","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.05.093_b0030","doi-asserted-by":"crossref","unstructured":"Zhu H, Lam TT-Y, Smith DK, Guan Y. Emergence and development of H7N9 influenza viruses in China. Curr Opin Virol 2016;16:106\u201313. <https:\/\/doi.org\/10.1016\/j.coviro.2016.01.020>.","DOI":"10.1016\/j.coviro.2016.01.020"},{"key":"10.1016\/j.vaccine.2018.05.093_b0035","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrd4529","article-title":"Advances in the development of influenza virus vaccines","volume":"14","author":"Krammer","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.vaccine.2018.05.093_b0040","first-page":"1","article-title":"Inactivated viral vaccines","author":"Nunnally","year":"2015","journal-title":"Vaccine Anal Strateg Princ Control"},{"key":"10.1016\/j.vaccine.2018.05.093_b0045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jviromet.2015.05.004","article-title":"Evaluation of different inactivation methods for high and low pathogenic avian influenza viruses in egg-fluids for antigen preparation","volume":"222","author":"Pawar","year":"2015","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2018.05.093_b0050","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1002\/pmic.201300096","article-title":"Surface modifications of influenza proteins upon virus inactivation by \u03b2-propiolactone","volume":"13","author":"She","year":"2013","journal-title":"Proteomics"},{"key":"10.1016\/j.vaccine.2018.05.093_b0055","doi-asserted-by":"crossref","first-page":"13675","DOI":"10.1021\/la2027175","article-title":"Effect of the \u03b2-propiolactone treatment on the adsorption and fusion of influenza A\/Brisbane\/59\/2007 and A\/New Caledonia\/20\/1999 virus H1N1 on a dimyristoylphosphatidylcholine\/ganglioside GM3 mixed phospholipids monolayer at the air-water interface","volume":"27","author":"Desbat","year":"2011","journal-title":"Langmuir"},{"key":"10.1016\/j.vaccine.2018.05.093_b0060","doi-asserted-by":"crossref","first-page":"6501","DOI":"10.1016\/j.vaccine.2012.07.036","article-title":"Effect of viral membrane fusion activity on antibody induction by influenza H5N1 whole inactivated virus vaccine","volume":"30","author":"Geeraedts","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.093_b0065","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/icb.2009.81","article-title":"The gamma-irradiated influenza vaccine and the prospect of producing safe vaccines in general","volume":"88","author":"Alsharifi","year":"2010","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2018.05.093_b0070","unstructured":"International Atomic Energy Agency. Manual on radiation sterilization of medical and biological materials; 1973."},{"key":"10.1016\/j.vaccine.2018.05.093_b0075","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1016\/j.vaccine.2015.06.043","article-title":"Systemic immune responses to an inactivated, whole H9N2 avian influenza virus vaccine using class B CpG oligonucleotides in chickens","volume":"33","author":"Singh","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.093_b0080","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/vim.2013.0124","article-title":"Effects of ligands for Toll-like receptors 3, 4, and 21 as adjuvants on the immunogenicity of an avian influenza vaccine in chickens","volume":"27","author":"St Paul","year":"2014","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2018.05.093_b0085","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3920\/BM2017.0088","article-title":"Gut microbiota modulates type I interferon and antibody-mediated immune responses in chickens infected with influenza virus subtype H9N2","volume":"9","author":"Yitbarek","year":"2018","journal-title":"Benef Microbes"},{"key":"10.1016\/j.vaccine.2018.05.093_b0090","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2460\/ajvr.1988.49.01.38","article-title":"Development and evaluation of an enzyme-linked immunosorbent assay for bovine antibody to Pasteurella haemolytica: constructing an enzyme-linked immunosorbent assay titer","volume":"49","author":"Sacks","year":"1988","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2018.05.093_b0095","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1089\/vim.2013.0129","article-title":"Avian influenza virus vaccines containing toll-like receptors 2 and 5 ligand adjuvants promote protective immune responses in chickens","volume":"27","author":"St Paul","year":"2014","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2018.05.093_b0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vetimm.2016.04.002","article-title":"Characterization of host responses induced by Toll-like receptor ligands in chicken cecal tonsil cells","volume":"174","author":"Taha-abdelaziz","year":"2016","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2018.05.093_b0105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1017\/S146625230800145X","article-title":"Interactions between commensal bacteria and the gut-associated immune system of the chicken","volume":"9","author":"Brisbin","year":"2008","journal-title":"Anim Health Res Rev"},{"key":"10.1016\/j.vaccine.2018.05.093_b0110","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1128\/CVI.00143-10","article-title":"Effects of lactobacilli on cytokine expression by chicken spleen and cecal tonsil cells","volume":"17","author":"Brisbin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.05.093_b0115","article-title":"Performance, histomorphology, and Toll-like receptor, chemokine, and cytokine profile locally and systemically in broiler chickens fed diets supplemented with yeast-derived macromolecules","author":"Yitbarek","year":"2012","journal-title":"Poult Sci"},{"key":"10.1016\/j.vaccine.2018.05.093_b0120","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1749-6632.2010.05829.x","article-title":"Structural basis of influenza virus neutralization","volume":"1217","author":"Han","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vaccine.2018.05.093_b0125","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.vaccine.2016.12.044","article-title":"The effect of gamma-irradiation conditions on the immunogenicity of whole-inactivated Influenza A virus vaccine","volume":"35","author":"David","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.093_b0130","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.3382\/ps.2013-03193","article-title":"Comparison of 3 kinds of Toll-like receptor ligands for inactivated avian H5N1 influenza virus intranasal immunization in chicken","volume":"92","author":"Liang","year":"2013","journal-title":"Poult Sci"},{"key":"10.1016\/j.vaccine.2018.05.093_b0135","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1128\/JVI.75.6.2516-2525.2001","article-title":"Cross-reactive, cell-mediated immunity and protection of chickens from lethal H5N1 influenza virus infection in Hong Kong poultry markets","volume":"75","author":"Seo","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.05.093_b0140","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.it.2014.06.004","article-title":"T cell mediated immunity to influenza: mechanisms of viral control","volume":"35","author":"La Gruta","year":"2014","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2018.05.093_b0145","doi-asserted-by":"crossref","unstructured":"Budimir N, Huckriede A, Meijerhof T, Boon L, Gostick E, Price DA, et al. Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: The role of viral membrane fusion activity. PLoS One 2012;7. 10.1371\/journal.pone.0030898.","DOI":"10.1371\/journal.pone.0030898"},{"key":"10.1016\/j.vaccine.2018.05.093_b0150","doi-asserted-by":"crossref","unstructured":"St. Paul M, Brisbin JT, Abdul-Careem MF, Sharif S. Immunostimulatory properties of Toll-like receptor ligands in chickens. Vet Immunol Immunopathol 2013;152:191\u20139. 10.1016\/j.vetimm.2012.10.013.","DOI":"10.1016\/j.vetimm.2012.10.013"},{"key":"10.1016\/j.vaccine.2018.05.093_b0155","doi-asserted-by":"crossref","unstructured":"Kapczynski DR. Detection of cell-mediated immune response to avian influenza viruses. In: Spackman E, editor. Anim Influ Viruses, New York, NY: Springer New York; 2014. p. 199\u2013215. 10.1007\/978-1-4939-0758-8_17.","DOI":"10.1007\/978-1-4939-0758-8_17"},{"key":"10.1016\/j.vaccine.2018.05.093_b0160","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1016\/j.febslet.2006.06.044","article-title":"Characterization of chicken interleukin 2 receptor \u03b1 chain, a homolog to mammalian CD25","volume":"580","author":"Teng","year":"2006","journal-title":"FEBS Lett"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1830759X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1830759X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T20:08:43Z","timestamp":1751659723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1830759X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":32,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0264410X1830759X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.05.093","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Examination of the effects of virus inactivation methods on the induction of antibody- and cell-mediated immune responses against whole inactivated H9N2 avian influenza virus vaccines in chickens","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.05.093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}